Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors

Taka-Aki Koshimizu1, Aki Kashiwazaki1, Junichi Taniguchi1

  • 1Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan.

Scientific Reports
|May 4, 2016
PubMed

Insights

Reducing extracellular sodium enhances agonist binding to G-protein coupled receptors (GPCRs) by minimizing receptor internalization. This study explored combined effects using vasopressin V1b receptors, finding specific ionic conditions optimize cell surface receptor presence.

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Extracellular sodium ions (Na+) can influence G-protein coupled receptor (GPCR) function, potentially affecting agonist binding and receptor trafficking.
  • Previous research has indicated Na+ can mediate a binding block and influence receptor internalization, but combined effects on cell surface receptor availability remain underexplored.

Purpose of the Study:

  • To investigate the impact of reduced extracellular Na+ on both agonist binding and receptor internalization for cell surface GPCRs.
  • To identify specific ionic conditions that can increase the presence of high-affinity receptors at the cell surface while minimizing agonist-induced internalization.

Main Methods:

  • Utilized Chinese Hamster Ovary (CHO) cells expressing vasopressin V1b receptors as a model system.
  • Manipulated extracellular Na+ concentrations and substituted Na+ with other ions (Cs+, NH4+) to assess effects on [(3)H]AVP binding and receptor internalization.
  • Investigated the role of different ionic concentrations and iso-osmotic supplements (glucose, NH4Cl) on V1b receptor trafficking.

Main Results:

  • Decreased extracellular Na+ significantly increased cell surface [(3)H]AVP binding and reduced receptor internalization.
  • Substitution of Na+ with Cs+ or NH4+ inhibited agonist binding, indicating ion-specific effects.
  • Suppression of receptor internalization required NaCl concentrations below 50 mM, highlighting Na+'s critical role in the internalization machinery.
  • Iodide ions were found to inhibit V1b agonist binding.

Conclusions:

  • Specific extracellular ionic conditions can be optimized to enhance the availability of high-affinity vasopressin V1b receptors at the cell surface.
  • Reducing extracellular Na+ concentration is a viable strategy to increase agonist binding while simultaneously decreasing receptor internalization.
  • The findings provide a foundation for understanding and manipulating GPCR cell surface dynamics in response to ionic environmental changes.

Related Concept Videos

Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.6K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.3K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.2K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K